Facebook
X
LinkedIn
Forward
Herbert Wertheim Cancer Institute Breast Cancer Performance and Quality Improvement
This online series features multidisciplinary experts from the Herbert Wertheim Cancer Institute focusing on advancing the care of patients with HER2-positive metastatic breast cancer.
Commercial Supporter
Baptist Health gratefully acknowledges the educational grants provided by Daiichi Sankyo, Inc. and AstraZeneca.
Target Audience
Breast Medical Oncologists, Radiation Oncologists, Emergency Medicine Physicians, Infusion Nurses, Nurse Navigators, Advanced Practice Registered Nurses, Pharmacists, Pharmacy Technicians, Physician Assistants/Physician Associates, Pulmonologists, Radiologists, Schedulers, Medical Assistants, Patient Care Facilitators, and all personnel involved in the care of the breast cancer patient.
Learning Objectives
Upon completion of this conference, participants should be better able to:
- Assess institutional needs and care gaps by analyzing baseline data on current practices in the management of metastatic breast cancer (mBC).
- Evaluate existing institutional procedures to identify opportunities for improvement, aiming to enhance proactive detection and early management of antibody–drug conjugate (ADC)–related adverse events (AEs) and strengthen interprofessional communication and care coordination.
- Determine necessary changes at both human and system levels to address identified practice gaps in the current management of mBC.
- Implement targeted strategies to facilitate earlier recognition of side effects, particularly interstitial lung disease (ILD), for patients receiving ADCs across multiple hospital departments, including the Emergency Room, Radiology, and Infusion Center.
New Baptist Health CME Course Catalog
The new Baptist Health CME Course Catalog makes it simple to find, explore, and register for activities that support your professional development.
Open Full Course Catalog
Reshma L. Mahtani, D.O.
Chief of Breast Medical Oncology
Miami Cancer Institute
Baptist Health South Florida
Member, Memorial Sloan Kettering Cancer Alliance
Reshma Mahtani, D.O., faculty of this educational activity, is a consultant for Agendia, Arvinas, AstraZeneca, Bicycle Therapeutics, Daiichi Sankyo, Genentech, Gilead, Hologic, Lilly, Novartis, Pfizer, Puma, and Stemline, and indicated that the presentation or discussion will include off-label or unapproved product usage.
All financial relationships have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose with ineligible companies*
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Artificial Intelligence (AI) Use Disclosure
For this activity, AI was used to assist in developing and refining assessment questions and learner feedback based on medical writer-authored content, and to help align assessments with competency-level outcome measures consistent with ACCME standards. All AI-assisted content received subject matter expert review, validation, and approval before use.
Disclosure Policy and Disclaimer
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of up to 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Required Hardware/Software
PC/Mac Users
This site is supported on the most recent stable releases of the following browsers:
Google Chrome
Microsoft Edge
Safari
Mozilla Firefox
Mobile Users
This site is supported on the following mobile devices:
- Apple iOS mobile devices running iOS 10 or later
- Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.